|
1
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Merican I, Guan R, Amarapuka D, et al:
Chronic hepatitis B virus infection in Asian countries. J
Gastroenterol Hepatol. 15:1356–1361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lupberger J and Hildt E: Hepatitis B
virus-induced oncogenesis. World J Gastroenterol. 13:74–81. 2007.
View Article : Google Scholar
|
|
4
|
Wang Y, Cui F, Lv Y, et al: HBsAg
and HBx knocked into the p21 locus causes
hepatocellular carcinoma in mice. Hepatology. 39:318–324. 2004.
View Article : Google Scholar
|
|
5
|
Pfeifer GP and Dammann R: Methylation of
the tumor suppressor gene RASSF1A in human tumors.
Biochemistry. 70:576–583. 2005.PubMed/NCBI
|
|
6
|
Hu L, Chen G, Yu H and Qiu X:
Clinicopathological significance of RASSF1A reduced expression and
hypermethylation in hepatocellular carcinoma. Hepatol Int.
4:423–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schagdarsurengin U, Wilkens L, Steinemann
D, et al: Frequent epigenetic inactivation of the RASSF1A
gene in hepatocellular carcinoma. Oncogene. 22:1866–1871. 2003.
View Article : Google Scholar
|
|
8
|
Zhong S, Yeo W, Tang MW, Wong N, Lai PB
and Johnson PJ: Intensive hypermethylation of the CpG island of Ras
association domain family 1A in hepatitis B virus-associated
hepatocellular carcinomas. Clin Cancer Res. 9:3376–3382.
2003.PubMed/NCBI
|
|
9
|
Bréchot C: Pathogenesis of hepatitis B
virus-related hepatocellular carcinoma: old and new paradigms.
Gastroenterology. 127(Suppl 1): S56–S61. 2004.PubMed/NCBI
|
|
10
|
Kim CM, Koike K, Saito I, Miyamura T and
Jay G: HBx gene of hepatitis B virus induces liver cancer in
transgenic mice. Nature. 351:317–320. 1991. View Article : Google Scholar
|
|
11
|
Yu DY, Moon HB, Son JK, et al: Incidence
of hepatocellular carcinoma in transgenic mice expressing the
hepatitis B virus X-protein. J Hepatol. 31:123–132. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park IY, Sohn BH, Yu E, et al: Aberrant
epigenetic modifications in hepatocarcinogenesis induced by
hepatitis B virus X protein. Gastroenterology. 132:1476–1494. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong A, Gou L, Lau QC, et al: Proteomic
profiling identifies aberrant epigenetic modifications induced by
hepatitis B virus X protein. J Proteome Res. 8:1037–1046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng DL, Zhang L, Cheng N, et al:
Epigenetic modification induced by hepatitis B virus X protein via
interaction with de novo DNA methyltransferase DNMT3A. J Hepatol.
50:377–387. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS
and Jang KL: Hepatitis B virus X protein represses E-cadherin
expression via activation of DNA methyltransferase 1. Oncogene.
24:6617–6625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Y, Zhu R, Shi L, et al: Hepatitis B
virus X protein promotes hypermethylation of p16INK4A
promoter through upregulation of DNA methyltransferases in
hepatocarcinogenesis. Exp Mol Pathol. 89:268–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan H, Zhao Z, Quan Y, Xu J, Zhang J and
Xie W: DNA methyltransferase 1 knockdown induces silenced CDH1 gene
reexpression by demethylation of methylated CpG in hepatocellular
carcinoma cell line SMMC-7721. Eur J Gastroenterol Hepatol.
19:952–961. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Fan H, Zhao ZJ, Zhang JQ and Xie W:
Identification of potential genes regulated by DNA
methyltransferase 3B in a hepatocellular carcinoma cell line by RNA
interference and microarray analysis. Yi Chuan Xue Bao.
32:1115–1127. 2005.(In Chinese).
|
|
19
|
Tao Q, Huang H, Geiman TM, et al:
Defective de novo methylation of viral and cellular DNA sequences
in ICF syndrome cells. Hum Mol Genet. 11:2091–2102. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kawaguchi Ki, Oda Y, Saito T, et al: DNA
hypermethylation status of multiple genes in soft tissue sarcomas.
Mod Pathol. 19:106–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dammann R, Li C, Yoon JH, Chin PL, Bates S
and Pfeifer GP: Epigenetic inactivation of a RAS association domain
family protein from the lung tumour suppressor locus 3p21.3. Nat
Genet. 25:315–319. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Chan THM, Yuan YF, et al: CHD1L
promotes hepatocellular carcinoma progression and metastasis in
mice and is associated with these processes in human patients. J
Clin Invest. 120:1178–1191. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan PS, Shi H, Rahmatpanah F, et al:
Differential distribution of DNA methylation within the RASSF1A CpG
island in breast cancer. Cancer Res. 63:6178–6186. 2003.PubMed/NCBI
|
|
24
|
Tommasi S, Dammann R, Zhang Z, et al:
Tumor susceptibility of Rassf1a knockout mice. Cancer Res.
65:92–98. 2005.PubMed/NCBI
|
|
25
|
Burbee DG, Forgacs E, Zöchbauer-Müller S,
et al: Epigenetic inactivation of RASSF1A in lung and breast
cancers and malignant phenotype suppression. J Natl Cancer Inst.
93:691–699. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hesson L, Bièche I, Krex D, et al:
Frequent epigenetic inactivation of RASSF1A and BLU
genes located within the critical 3p21.3 region in gliomas.
Oncogene. 23:2408–2419. 2004.
|
|
27
|
Dreijerink K, Braga E, Kuzmin I, et al:
The candidate tumor suppressor gene, RASSF1A, from human
chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl
Acad Sci USA. 98:7504–7509. 2001.PubMed/NCBI
|
|
28
|
Kuzmin I, Gillespie JW, Protopopov A, et
al: The RASSF1A tumor suppressor gene is inactivated in
prostate tumors and suppresses growth of prostate carcinoma cells.
Cancer Res. 62:3498–3502. 2002.
|
|
29
|
Chow LS, Lo KW, Kwong J, et al:
RASSF1A is a target tumor suppressor from 3p21.3 in
nasopharyngeal carcinoma. Int J Cancer. 109:839–847. 2004.
View Article : Google Scholar
|
|
30
|
Li J, Wang F, Protopopov A, et al:
Inactivation of RASSF1C during in vivo tumor growth
identifies it as a tumor suppressor gene. Oncogene. 23:5941–5949.
2004.
|
|
31
|
Fuks F, Burgers WA, Brehm A, Hughes-Davies
L and Kouzarides T: DNA methyltransferase Dnmt1 associates with
histone deacetylase activity. Nat Genet. 24:88–91. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rountree MR, Bachman KE and Baylin SB:
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex
at replication foci. Nat Genet. 25:269–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Robertson KD, Ait-Si-Ali S, Yokochi T,
Wade PA, Jones PL and Wolffe AP: DNMT1 forms a complex with Rb,
E2F1 and HDAC1 and represses transcription from E2F-responsive
promoters. Nat Genet. 25:338–342. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Höller M, Westin G, Jiricny J and
Schaffner W: Sp1 transcription factor binds DNA and activates
transcription even when the binding site is CpG methylated. Genes
Dev. 2:1127–1135. 1988.PubMed/NCBI
|
|
35
|
Pieper RO, Patel S, Ting SA, Futscher BW
and Costello JF: Methylation of CpG island transcription factor
binding sites is unnecessary for aberrant silencing of the human
MGMT gene. J Biol Chem. 271:13916–13924. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Strunnikova M, Schagdarsurengin U, Kehlen
A, Garbe JC, Stampfer MR and Dammann R: Chromatin inactivation
precedes de novo DNA methylation during the progressive epigenetic
silencing of the RASSF1A promoter. Mol Cell Biol.
25:3923–3933. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sawadogo M and Roeder RG: Interaction of a
gene-specific transcription factor with the adenovirus major late
promoter upstream of the TATA box region. Cell. 43:165–175. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo X and Sawadogo M: Functional domains
of the transcription factor USF2: atypical nuclear localization
signals and context-dependent transcriptional activation domains.
Mol Cell Biol. 16:1367–1375. 1996.
|
|
39
|
Roy AL, Du H, Gregor PD, Novina CD,
Martinez E and Roeder RG: Cloning of an inr-and E-box-binding
protein, TFII-I, that interacts physically and functionally with
USF1. EMBO J. 16:7091–7104. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Majumder S, Ghoshal K, Li Z, Bo Y and
Jacob ST: Silencing of metallothionein-I gene in mouse
lymphosarcoma cells by methylation. Oncogene. 18:6287–6295. 1999.
View Article : Google Scholar : PubMed/NCBI
|
